XOMA
XOMA is a biotechnology company specializing in the discovery, development, and licensing of innovative therapeutic antibodies. With a focus on advancing biologics to address unmet medical needs, XOMA leverages its extensive antibody engineering expertise and robust portfolio of intellectual property to support pharmaceutical partners worldwide. The company’s business model centers on generating revenue through milestone payments and royalties from its diverse portfolio of partnered assets. XOMA’s commitment to scientific excellence and strategic collaborations positions it as a key player in the biopharmaceutical industry, driving progress in antibody-based therapies for a range of diseases.
